Table 1.
Model | Phenotype | References |
---|---|---|
acute hypertension | ↓EDR | 8 |
chronic hypertension | ↑ROS, ↑Nox, ↓EDR, ↓NVC hypertrophy | 9, 25, 26, 38, 60 |
hyperhomocysteinemia | ↑ROS, ↓EDR, hypertrophy | 23, 30 |
insulin resistance | ↑ROS, ↑Nox, ↓EDR ↓K+ channel-induced vasodilation |
13, 28 |
hypercholesterolemia | ↑ROS ↑blood cell-vessel interactions |
69 |
diabetes/metabolic syndrome | ↑ROS, ↑Nox, ↓EDR ↓hypoxia-induced vasodilation ↓glutamate-induced vasodilation |
14, 29, 35, 64, 86 |
inflammation | ↑ROS, ↓EDR, | 18, 54 |
hypoxia | ↑ROS, ↓EDR, | 87 |
sickle cell disease | ↑blood cell-vessel interactions | 70 |
subarachnoid hemorrhage | ↑ROS, ↑Nox, vasospasm | 39, 40, 66 |
ischemia with reperfusion | ↓EDR, ↓vasoconstriction | 24 |
meningitis | vasodilation | 88 |
traumatic brain injury | ↓EDR, ↓vasoconstriction | 27 |
Alzheimer’s disease | ↑ROS, ↓EDR, ↓NVC | 20, 21 |
aging | ↑ROS, ↑Nox, ↓EDR, ↓NVC, | 12, 19 |
nicotine | ↓EDR | 10 |
alcohol | ↑ROS, ↓EDR, ↓K+ channel-induced vasodilation | 22, 36 |
methionine synthase deficiency | ↑ROS, ↓EDR | 31 |
SOD deficiency | ↑ROS, ↓EDR, hypertrophy ↑vasoconstriction |
11, 15, 16 |
PPARγ interference | ↑ROS, ↓EDR, hypertrophy, | 17 |
EDR = endothelium-dependent relaxation
NVC = neurovascular coupling
ROS = reactive oxygen species in the vasculature
Nox = activity or expression of NADPH oxidase